Locations
Scantox is a leading European contract research organization (CRO) offering a comprehensive portfolio of drug discovery, development and CMC/Analytical services to support pharmaceutical, biotech and medical device industries. Located in Denmark since 1977, the company began an international journey of expansions in 2022 with the establishment of Scantox Sweden, and in 2024 Scantox Neuro in Austria was added to the Scantox Group.
Scantox Group, Headquarters
Scantox A/S, Denmark
The Scantox Group Headquarters has since 1977 been based in Lille Skensved, located just 30 minutes from Copenhagen. This is the location where the company was also originally founded.
Scantox is one of the largest employers in the region, and a sought after partner for pharma and biotech companies around the world for a unique expertise and long track record. Current premises cover an area exceeding 8,500 m2, where all phases of the scientific research process take place.
The company has over the years made continuous investment in advanced housing facilities according to EU Directive 2010/63/EU, as well as in state-of-the-art laboratories, and meet and exceed the industry’s highest quality standards.
Scantox is fully licensed by Danish Authorities, and all processes are carried out on the most reliable equipment available in the industry today.
Scantox A/S
Hestehavevej 36A, Ejby
4623 Lille Skensved
Denmark
Tel: +45 5686 1500
Contact
Sales: clientservice@scantox.com
Human Resources: hr@scantox.com
Finance: finance@scantox.com
Marketing: marketing@scantox.com
Scantox Sweden
In 2022 Scantox acquired the two Swedish CRO’s – Timeline Bioresearch in Lund and Adlego Biomedical, located in Solna near Stockholm. In 2023 an additional entity was added to the Group, with the acquisition of Q&Q Labs AB in Gothenburg. The three entites are now Scantox Sweden.
The Swedish expansions brought leading capabilities within in efficacy, explorative research services and bioanalytical services; expanding the Scantox portfolio of offerings.
Scantox Lund
Medicon Village
Sheelevägen 2
223 63 Lund, Sweden
info-lund@scantox.com
Scantox Solna
Karolinska Science Park
Nobels väg 16
171 65 Solna, Sweden
info-solna@scantox.com
Scantox Gothenburg
AstraZeneca BioVentureHub
Pepparedsleden 3
431 83 Mölndal, Sweden
info-gothenburg@scantox.com
Scantox Denmark
In 2023 Scantox acquired Solural Pharma, located in Ballerup. The location in Ballerup has strong expertise in all aspects of formulation development, GMP manufacturing and packaging to support phase 1 & 2 clinical trials. Scantox Ballerup develops formulations, from concept idea to clinical proof of concept, and our formulation technology platform provides innovative oral and topical products having unique benefits regarding efficacy, safety and convenience thereby meeting the needs from patients, doctors and society alike for the treatment of important medical conditions.
Scantox Ballerup
Energivej 42
2750 Ballerup, Denmark
info-ballerup@scantox.com
Scantox Neuro GmbH, Austria
Scantox Neuro GmbH, based in Austria, belongs to the Discovery Business Unit of Scantox Group, focusing on preclinical studies in CNS diseases, Rare Diseases and Mental Disorders. The on-site availability of highly predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes makes Scantox the first choice for most CNS drug development needs. The site was integrated into the Scantox Group in April 2024.
Scantox Neuro GmbH
Parkring 12
8074 Grambach
Austria
+43 316 258111
office-austria@scantox.com
www.scantoxneuro.com
Scantox locations
Scantox is headquartered in Denmark with a number of international subsidiaries enabling us to provide a wide range of CRO services in the various stages of the drug development process.